Wells Fargo downgraded Myriad Genetics (NASDAQ: MYGN) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.

Shares of Myriad Genetics closed at $29.46 yesterday.

Downgrades

Jefferies Remains Sidelined on Myriad Genetics (MYGN) Following 4Q August 11, 2016 8:37 AM Mizuho Securities Cuts Price Target on Myriad Genetics (MYGN) to $22 Following 4Q and Guidance August 10, 2016 7:19 AM Piper Jaffray Downgrades Myriad Genetics (MYGN) to NeutralAugust 10, 2016 6:38 AM Myriad Genetics (MYGN) Misses Q4 EPS by 6c; Issues Weak Q1, FY17 OutlookAugust 9, 2016 4:11 PM Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial ResultsAugust 9, 2016 4:06 PM